Voxalatamab
Product Specifications
UNSPSC Description
Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research[1].
Target Antigen
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/voxalatamab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Voxalatamab]
References & Citations
[1]Jonas S Heitmann, et al. Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives. Cancers (Basel). 2021 Feb 1;13(3):549.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99517/Voxalatamab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99517/Voxalatamab-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
2411871-58-2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Influenza A H1N1 (A/swine/Alberta/SD0154/2016) Neuraminidase/NA (His Tag) HEK293 Cell Lysate (WB positive control)
Influenza A H1N1 (A/swine/Alberta/SD0154/2016) Neuraminidase/NA (His Tag) HEK293 Cell Lysate (WB positive control)